Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.
Condition:   Insulin Resistance Interventions:   Drug: Metformin group;   Drug: Rosiglitazone group;   Drug: Placebo oral tablet Sponsors:   J JESUS VENEGAS, MD;   Instituto Mexicano del Seguro Social;   National Council of Science and Technology, Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
Conditions:   Melanoma;   Renal Cell Carcinoma;   NSCLC;   Hepatocellular Carcinoma;   Urothelial Cancer;   Gastric Adenocarcinoma;   HNSCC;   Esophageal Adenocarcinoma;   Microsatellite Instability-High Solid Malignant Tumor Interventions:   Drug: Nivolumab or Pembrolizumab (dependent upon approved indication);   Drug: Metformin;   Drug: Rosiglitazone Sponsor:   Dan Zandberg Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2019 Category: Research Source Type: clinical trials